The smart way to manage your genomics data analysis
Bluebee’s unique private cloud-based accelerated genomics analysis platform enables fast, efficient and affordable processing of Next Generation Sequencing data. Be it for research, clinical applications, agrigenomics, or beyond, Bluebee’s secure, scalable, and configurable platform supports cross-functional teams with centralized sequence data analysis and storage.
Bluebee adds NEN 7510:2011 Certification to its Security Portfolio
The security of Bluebee’s customer data is a priority highlighted by the recent NEN 7510:2011 certification, and demonstrates the company’s continued strive for security compliance and excellence in handling healthcare data.
Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market
Bluebee and Agendia, Inc, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit, which is intended for prognostic use in a clinical setting.
PacBio and Bluebee Launch De Novo Genome Assembly Pipeline on the Bluebee Analysis Platform
October 9th, 2017 — Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, announced they have integrated the PacBio® de novo assembly pipeline onto the Bluebee® genomics analysis platform.